Cargando…

New developments in acne treatment: role of combination adapalene–benzoylperoxide

The fixed-dose combination adapalene 0.1%/benzoylperoxide 2.5% (A/BPO) was introduced as an acne vulgaris therapeutic in 2007. It combines anti-inflammatory, keratolytic, comedolytic, and antibacterial properties. Thus, it addresses several pathophysiological factors involved in the pathophysiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su Youn, Ochsendorf, Falk R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055040/
https://www.ncbi.nlm.nih.gov/pubmed/27757036
http://dx.doi.org/10.2147/TCRM.S94062

Ejemplares similares